medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2013, Number 3

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2013; 12 (3)

Transfusional standards in the surgical patient

García GE

Language: Spanish
References: 44
Page: 231-243
PDF size: 75.13 Kb.


ABSTRACT

Introduction: with the objective of promoting blood safety, the World Health Organization develops strategies to reduce unnecessary transfusions through the appropriate clinical use of blood. Different scientific societies sponsor clinical practice guides about transfusion indications.
Objective: to deepen into the knowledge about the basic principles for the proper use of blood and its components that is linked to surgical patient care.
Development: surgical patients are high blood transfusion consumers. In spite of the existence of clinical guides, unnecessary transfusions are used and there is a great variability of criteria to determine the need for transfusion, which are often complex and of difficult application. The use of the different blood components must be guided by transfusional policies and guidelines. The fulfillment of protocols and the existence of clinical guides for their proper use will indeed help to reduce unnecessary transfusions and the great variability in the criteria to decide the biological drug administration that should be based on clinical parameters and complementary examinations.
Conclusions: after reviewing different transfusional guideline proposals made by specialists linked to blood transfusion and especially, the ones belonging to our National Blood Commission (ABC of Transfusion Medicine: Clinical Guidelines), it is intended to contribute modestly to deepen into the knowledge about the basic principles for the proper use of blood and its components that everyone involved in the surgical patient care should have.


REFERENCES

  1. Departament of Health and Human Services. (US). The 2009 national blood collection and utilization survey report. Washington (DC): Departament of Health and Human Services, Office of the Assistant Secretary of Health; 2011.

  2. Food and Drug Administration (US). Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2010. Washington (DC): Food and Drug Administration; 2011.

  3. Vargas MC. Uso de hemocomponentes en la práctica médica e implicaciones legales. MedLeg Costa Rica [serial online] 2011 Sep. [citado 3 Oct. 2012]; 28(2): [11 pantallas]. Disponible en: URL: http://www.scielo.sa.cr/scielo.php?pid=S1409 -00152011000200005&script=sci_arttext&tlng=pt

  4. García C MC. Ética y calidad en los servicios de sangre. Acta Bioeth 2011; 17 (1): 55-59.

  5. Sanzama K. The ethics of blood management. Vox Sanguinis 2007; 92(2):103-112.

  6. Nel TJ. Clinical guidelines, audits and hemovigilance in menagin blood transfusion needs. TATM 2008; 10(2):61-9.

  7. Ballester SJM. ABC de la Medicina Transfusional: Guías Clínicas. Ciudad de la Habana: Instituto de Hematología e Inmunología. Programa Nacional de Sangre. MINSAP; 2006.

  8. Rivero JR. Transmisión de infecciones bacterianas y parasitarias por transfusiones de sangre y sus componentes. Rev Cubana HematolInmunolHemoter 2008; 24(4): 1-20.

  9. Morris A. Vanmvaka EC. The Continuing Risk of Transfusion Transmitted Infections. N Engl J Med 2006; 355 (13): 1303-05.

  10. Middelburg R, Van de Watering L, Van der Bom J. Blood transfusions:good or bad? Transfusion 2010; 50 (6):1181-3.

  11. García GE, Arias CN, Raola S ME. Consumo de transfusiones sanguíneas en cirugía electiva con riesgo moderado o alto de sangramiento. Rev Cubana MedMilit [serial online] 2007 Jul-Sept; 36(3): [8 pantallas]. Disponible en: URL: http://bvs.sld.cu/revistas/mil/vol36_3_07/mil02307.html .

  12. Leal R, Alberca I, Asuero S, Bóveda JL, Carpio N, Contreras E. Documento «Sevilla» de Consenso sobre alternativas a la Transfusión de Sangre Alogénica. MedClin (Barc) 2006; 27(1):3-20.

  13. Rodríguez MH. Medicina sin Transfusiones. Rev Med IMSS 2005; 43 (3): 229-35.

  14. Gardner J. To transfuse or not transfuse. Circulation 2007; 118 (4): 458-60.

  15. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et al. Clinical practice guideline: Red blood cell, transfusion in adult trauma and critical care. Crit Care Med 2009; 37 (12): 3124-57.

  16. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: A systematic review to the literature. Crit Care Med 2008 Sep. 36 (9): 2667-74.

  17. Gómez BR Alfonso FD, Dita SL, Núñez AL. Guía de práctica clínica para la transfusión a pacientes en estado crítico. Medisur [serial online] 2009 [citado 8 Nov. 2012]; 7 (1): [10 pantallas]. Disponible en: URL: http://redalyc.uaemex.mx/src/inicio/ArtPdfRed.jsp?iCve=180020082007

  18. Sadaka F, Aggu-SR, Krause K, O´Brien J, Ambrecht ES, Taylor RW. The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septicpatients. Ann Intensive Care 2011; 8 (1): 46.

  19. Organización Mundial de la Salud. El uso clínico de la sangre. Manual de bolsillo. Ginebra. OMS. 2001.

  20. Surgenor SD, Wall MH. Changing Concepts of Transfusions Triggers: Lessons from the ICU. ASA Newsletter 2006; 70 (4):1-8.

  21. RoseftSD. Guideline for Transfusion: A way to decrease transfusion. TATM 2008; 6 (2):27-36.

  22. Organización Panamericana de la Salud. Estándares de Trabajo para Servicios de Sangre, Políticas y Regulaciones. Washington DC. 2005.

  23. Sociedad Española de Transfusión Sanguínea. Guías sobre la transfusión de componentes sanguíneos y derivados plasmáticos. 3era ed: Madrid. 2006.

  24. Gwen C, Morris B, editors. Clinical Guide to Transfusion [monografía en Internet]. Canadian Blood Service; 2007. [citado 12 Nov. 2012]. Disponible en: URL: http://www.transfusionmedicine.ca/resources/clinical-guide-transfusion

  25. American Society of Anesthesiologist. Practical Guideline for Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006; 105 (1):198-208.

  26. Fuller A, Bucklin B. Blood Component Therapy in Obstetrics. ObstetGynecolClin N Am 2007; 34: 443-58.

  27. Hofmann A. Blood use in surgery elective: The Austrian bench mark study transfusion 2007; 47(8): 1468-80.

  28. Jackson JN, Snowden CA, Indrikovs AJ. A Prospective Audit Program to Determine Blood Component Transfusions Appropriateness at a Large University Hospital: A 5 Year Experience. Transfusion Medicine Reviews 2008; 22 (2) 154-61.

  29. Vuille LE, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy J F. Transfusión de glóbulos rojos en la práctica de la cirugía electiva: un estudio de cohorte multicéntrico. Transfusión 2010; 50 (10): 2117-24.

  30. Snyder-Ramos SA, Mohnler P, Weng YS, Bottiger BW, Kulier A, Levin J, etal. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 2008; (7): 1284-99.

  31. Carson JL, Grossman BJ. ¿Cuándo hacer transfusiones de glóbulos rojos? Ann Intern Med E [serial online] 2012. Mar [citado 15 Nov. 2012]; 7 (1): [3 pantallas]. Disponible en: URL: http://www.intramed.net/contenidover.asp?contenidoID=75242

  32. So-Osman CS, Nelissen R, Slaa RT, Coene L, Brand R, Brand A. A randomized comparison of transfusion triggers in elective orthopedic surgery using leucocyte-depleted red blood cells. VoxSanguinis 2009. Jan; 98 (1): 56-64.

  33. Bennett-Guerrero E, Zhao Y, O´Brien SM, Ferguson TB, Peterson ED, Gammie JS, et al. Variation in use of blood transfusión in coranary artery bypasses graft surgery. JAMA 2010; 304: 1568-75.

  34. Rodríguez MH. Indicaciones para transfusión de Eritrocitos: concentración de la hemoglobina y características de la anemia: Rev Med IMSS 2005; 42 (2): 145-54.

  35. Asensio JA, Rojo E, Petrone P, Karsidag T, Pardo M, Demiray S y cols. Síndrome de exanguinación. Factores predictivos e indicativos para la cirugía de control de daños. CirEsp 2003; 73 (2) 120-9.

  36. Jochen DM, Simon CB. Impact of genetic variation on perioperative bleeding. Am J Hematol 2008. Sep; 83 (9): 732-7.

  37. Corwin HL, Carson JL Blood Transfusion When is more really less?NEngl J Med 2007; 350(16): 1667- 69.

  38. Carson JL, Terrin ML, Noveck H, Sander DW, Chaitman BR, Rhoods GG, et al. Liberal or Restrictive Transfusion in High-Risk Patient after Hip Surgery. N Engl J Med 2011; 365: 2453-62.

  39. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés, et al. Task Force for Diagnosis and Treatment of Non-ST- Segment Elevation Acute Coronary Syndromes of European Society of Cardiology. Guidelines for the diagnosis and treatment of non-ST- segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-660.

  40. Pardo JM, Panqueva MV, Espinosa AF. Rompiendo un mito en el control de la hemologlobina/hematocrito postransfusión. Acta Med Colomb [serial online]. 2010 Jan-Mar [citado 17 Nov. 2012]; 35 (1): [5 pantallas]. Disponible en: URL: http://www.scielo.org.co/pdf/amc/v35n1/v35n1a02.pdf

  41. Ozgonenel B, O´ Malley B, Krishen P, Eisembrey AB. Warfarin reversal emerging as the major indication for fresh frozen plasma use to a Tertiary Care Hospital. Am J Hematology 2007; 82 (12): 1091-94.

  42. Spahr JE, Rodgers GM. Treatment of immune mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients. Am J Hematology 2008; 83 (2): 122 25.

  43. Callejo HM, Núñez JM, Zamora P, Martínez LH. Beneficio y seguridad de la trasfusión de glóbulos rojos O positivo en la resucitación del choque hemorrágico. Rev Cubana Med Intensiva Emerg [serial online] 2007 [citado 20 Nov. 2012]; 6 (4): [5 pantallas]. Disponible en: URL: http://bvs.sld.cu/revistas/mie/vol6_4_07/mie02407.htm

  44. Cortés A, Wedekin W, Bolaños F. Reanimación con glóbulos rojos Rh positivos y sin prueba cruzada en emergencias médicas. ColombMed 2004; 35: 185-90.




2020     |     www.medigraphic.com